Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on October 30, 2014, regarding events occurring on October 29, 2014. Acadia Healthcare Company, Inc. (Acadia) entered into a definitive agreement to acquire CRC Health Group, Inc. (CRC), a behavioral healthcare provider majority-owned by investment funds affiliated with Bain Capital Partners, LLC.
Key Financial Metrics and Transaction Terms
- Total Consideration: Estimated aggregate consideration of approximately $1.175 billion.
- Debt Repayment: Approximately $875 million of the consideration is designated for the repayment of CRC's net indebtedness at closing.
- Equity Issuance: Acadia will issue up to 6.3 million shares of its common stock to accredited investors of CRC. This amount is subject to reduction based on cash payments to unaccredited investors, transaction expenses, and working capital adjustments.
- Cash Consideration: Unaccredited investors and holders of certain equity awards (Options and RSUs) will receive cash based on the market value of the common stock.
- Financing Commitments: Acadia secured commitments from Merrill Lynch, Bank of America, and Jefferies Finance LLC for a new senior secured term B facility (up to $580 million) and senior unsecured bridge loans ($250 million). A backstop revolving credit facility ($300 million) and term A facility ($294.4 million) are also committed if the amendment to the existing credit agreement is not effective by closing.
Material Changes and Agreements
The filing details the entry into a Material Definitive Agreement (Merger Agreement) and several related agreements:
- Merger Structure: A newly formed subsidiary of Acadia will merge with and into CRC, with CRC surviving as a wholly-owned subsidiary.
- Stockholders Agreement: An Amended and Restated Stockholders Agreement was executed with Waud Capital Partners and Bain Capital affiliates. This grants Waud Capital the right to designate one additional board nominee for a three-year term and includes a standstill provision preventing Bain Capital from acquiring additional shares or mounting a proxy contest.
- Registration Rights: A new agreement requires Acadia to file registration statements for securities held by Waud Capital and those issued to Bain Capital in the merger.
- Termination Fee: Under specified circumstances, Acadia may be required to pay CRC a termination fee of $50.0 million.
Guidance, Outlook, and Risks
Outlook: Acadia expects to complete the acquisition during the first quarter of 2015. The company is not required to consummate the merger until the completion of a 25-day marketing period for its debt financing.
Conditions to Closing: The transaction is subject to customary conditions, including the expiration of the Hart-Scott-Rodino Act waiting period, receipt of healthcare regulatory approvals, and the absence of a material adverse effect. Additionally, CRC's funded indebtedness immediately prior to closing must not exceed $955.3 million.
Risks: There is no assurance that the debt financing will be consummated prior to closing. The filing includes standard forward-looking statement disclaimers regarding risks and uncertainties that could cause actual results to differ materially from expectations.
Investor Verification Checklist
- Verify the final number of shares to be issued, as the 6.3 million figure is subject to adjustments for cash payments and working capital.
- Confirm the status of the 25-day debt marketing period and the finalization of long-term debt financing to replace bridge loans.
- Monitor the receipt of necessary healthcare regulatory approvals and the expiration of the HSR waiting period.
- Review the full text of the Merger Agreement (Exhibit 2.1) for specific representations, warranties, and termination rights.
- Assess the impact of the new Stockholders Agreement on corporate governance and the standstill provisions regarding Bain Capital.